SCHEMBL7045906

SCHEMBL7045906

CC[CH]OCCN1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
MAPK1 P28482 2/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
HTR2A P28223 1/20 0.44
SCN1A P35498 1/20 0.44
HTR2B P41595 1/20 0.44
KCNH2 Q12809 1/20 0.44
SCN2A Q99250 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
SCN3A Q9NY46 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
POLB P06746 1/20 0.40
SYK P43405 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3387923 0.76 ALDH1A1 (0.42) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL197295 0.76 GLA (0.42) ALDH1A1LMNAKDM4ESMN1; SMN2KEAP1
SCHEMBL474810 0.74 ALDH1A1 (0.51) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL18672765 0.73 ALDH1A1 (0.44) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL81823 0.73 TDP1 (0.56) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL14524633 0.72 ALDH1A1 (0.50) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
Bromide SCHEMBL2354924 0.72 ALDH1A1 (0.50) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL3305244 0.72 ALDH1A1 (0.54) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL111438 0.72 TSHR (0.58) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL19035795 0.72 ATM (0.42) ALDH1A1MAPK1CYP1A2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474420-A1 QUINAZOLINE COMPOUNDS Astrazeneca AB (SE) 2004-11-10 EP disclosed
WO-2003064413-A1 QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-07 WO disclosed
EP-1311500-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY AstraZeneca AB (SE) 2003-05-21 EP disclosed
WO-2002012227-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY ASTRAZENECA AB (SE) 2002-02-14 WO disclosed